Hemo Organic Receives ₹2.76 Cr Warrant Consideration

Hemo Organic Ltd announced the receipt of the second tranche of convertible warrant consideration amounting to ₹2,76,25,000. This payment is from non-promoter category allottees. Upon full conversion of the 34,00,000 outstanding warrants, the company's paid-up equity share capital is expected to increase from ₹3,46,59,000 to ₹6,86,59,000. This increase represents 34,65,900 equity shares of ₹10 each growing to 68,65,900 equity shares of ₹10 each, subject to regulatory approvals and completion of the process.